Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 10/29/2019 (Notice of voluntarily dismissal)

Filing Date: September 18, 2019

According to the Complaint, Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions.

This action stems from a proposed transaction announced on August 8, 2019, pursuant to which Corindus Vascular Robotics, Inc. will be acquired by Siemens Medical Solutions UA, Inc.

On August 7, 2019, Corindus’s Board of Directors caused the Company to enter into an agreement and plan of merger with Siemens. Pursuant to the terms of the Merger Agreement, Corindus’s stockholders will receive $4.28 in cash for each share of Corindus common stock they own.

On August 30, 2019, Defendants filed a Proxy Statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.

This case was voluntarily dismissed on October 29, 2019.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.